%0 Journal Article %A Fadini, Gian %A Bonora, Benedetta %A Zatti, Giancarlo %A Vitturi, Nicola %A Iori, Elisabetta %A Marescotti, Maria %A Albiero, Mattia %A Avogaro, Angelo %D 2017 %T MOESM1 of Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial %U https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Effects_of_the_SGLT2_inhibitor_dapagliflozin_on_HDL_cholesterol_particle_size_and_cholesterol_efflux_capacity_in_patients_with_type_2_diabetes_a_randomized_placebo-controlled_trial/4817356 %R 10.6084/m9.figshare.c.3734152_D1.v1 %2 https://springernature.figshare.com/ndownloader/files/7985848 %K Atherosclerosis %K Body composition %K Therapy %X Additional file 1. Supplemental data on cholesterol efflux capacity and bioimpedance vector analysis. %I figshare